---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-24-000087"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:57:22.156949+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Tarsus Pharma annual meeting elects two Class I directors, ratifies Ernst & Young auditor

## Summary
- Bhaskar Chaudhuri (21.8M for, 2.9M withheld) and William Link (20.8M for, 3.9M withheld) elected as Class I directors.
- Ratification of Ernst & Young as auditor for FY2024: 31.9M for, 24.9K against, 57.3K abstain.
- Total shares voted: 31,978,938 out of 37,776,665 outstanding, quorum achieved.

## SEC filing metadata
- accession: 0001819790-24-000087
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000087/0001819790-24-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979024000087/tars-20240613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-24-000087
- JSON: https://secwatch.observer/filing/0001819790-24-000087.json
- Plain text: https://secwatch.observer/filing/0001819790-24-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.